CD8A and neoplasm: Regulating the mTOR signaling pathway (by inhibiting glycolysis) showed strong antitumor immune responses through promoting the development of memory CD8+ T cells that can replicate rapidly upon second exposure to tumor antigen, allowing more sufficient clearance of tumor cells [171,172].